Document:

Exhibit 4.5

 

Monocle
Acquisition Corporation

 

DESCRIPTION OF SECURITIES

 

The following summary
of the material terms of the securities of Monocle Acquisition Corporation, a Delaware corporation (“we,” “us,”
 “our” or “the company”), is not intended to be a complete summary of the rights and preferences of such
securities and is subject to and qualified by reference to our amended and restated certificate of incorporation, our bylaws and
the warrant agreement, dated February 6, 2019, between the company and Continental Stock Transfer & Trust Company (the “Warrant
Agreement”), in each case incorporated by reference as exhibits to the company’s Annual Report on Form 10-K for the
year ended December 31, 2019 (the “Report”), and applicable Delaware law, including the Delaware General Corporation
Law, or DGCL. We urge you to read our amended and restated certificate of incorporation, our bylaws and the Warrant Agreement in
their entirety for a complete description of the rights and preferences of our securities.

 

Certain Terms

 

In this document,
unless the context otherwise requires:

 

	•	references
    to our “sponsor” refer to Monocle Partners, LLC, a Delaware limited liability company affiliated with our executive
    officers and certain of our directors;
	 	 
	•	references
    to “founders” refer to our sponsor and Cowen Investments;
	 	 
	•	references
    to “public units” refer to the units sold in our initial public offering;
	 	 
	•	references
    to “public shares” refer to shares of our common stock sold as part of the public units in our initial public
    offering;
	 	 
	•	references
    to “public warrants” refer to our redeemable warrants sold as part of the public units in our initial public offering;
	 	 
	•	references
    to “final prospectus” refer to the final prospectus for our initial public offering filed with the Securities
    and Exchange Commission, or the SEC, on February 7, 2019;
	 	 
	•	references
    to “founder shares” refer to shares of our common stock initially purchased by our founders in a private placement
    or placements prior to our initial public offering;
	 	 
	•	references
    to “private units” refer to the units sold to our founders in a private placement in connection with our initial
    public offering;
	 	 
	•	references
    to “private shares” refer to the shares of our common stock sold as part of the private units;
	 	 
	•	references
    to “private warrants” refer to the warrants sold as part of the private units;
	 	 
	•	references to “common stock”
refer to our common stock, par value $0.0001 per share;
	 	 
	•	references to “public stockholders”
refer to the holders of our public shares, including our sponsor, officers and directors to the extent they purchase public shares,
provided that their status as “public stockholders” shall only exist with respect to such public shares;
	 	 
	•	references to “management”
refer to our officers and directors;
	 	 
	•	references to “initial stockholders”
refer to the holders of our founder shares prior to our initial public offering; and
	 	 
	•	references to “Cowen Investments”
refer to Cowen Investments II LLC.

 

General

 

We are a Delaware
corporation formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization
or other similar business combination with one or more businesses, which we refer to in this document as our initial business combination,
and our affairs are governed by our amended and restated certificate of incorporation, our bylaws and Delaware law, including the
DGCL. As of the date of the Report, we are authorized to issue 200,000,000 shares of common stock, par value $0.0001 per share,
and 5,000,000 shares of preferred stock, par value $0.0001 per share. As of the date of the Report, 22,280,000 shares of common
stock are outstanding and no shares of preferred stock are outstanding. The following description summarizes the material terms
of our securities. For a complete description you should refer to our amended and restated certificate of incorporation, our bylaws
and the Warrant Agreement, and to the applicable provisions of Delaware law. Because it is only a summary, it may not contain all
the information that is important to you.

 

    

     

    

 

Units

 

Each unit consists
of one share of common stock and one warrant to purchase one share of common stock for a price of $11.50 per share of common stock,
subject to adjustment (as more fully described in our final prospectus). Holders will need to have their brokers contact our transfer
agent in order to separate the units into shares of common stock and warrants. The warrants will become exercisable 30 days after the completion of our initial business combination. The warrants will expire
at 5:00 p.m., New York City time, on the fifth anniversary of our completion of an initial business combination, or earlier upon
redemption or liquidation; provided, however, that the private warrants issued to Cowen Investments will not be exercisable more
than five years from February 6, 2019. The common stock and warrants underlying the units began to trade separately on February
28, 2019, and holders have the option to continue to hold units or separate their units into the component pieces.

 

Common Stock

 

As of the date of
the Report, 22,280,000 shares of common stock outstanding, consisting of 17,250,000 public shares, 717,500 private shares held
by our founders and 4,312,500 founder shares held by the initial stockholders.

 

Holders of record
of our common stock are entitled to one vote for each share of our common stock held on all matters to be voted on by stockholders.
Unless specified in our amended and restated certificate of incorporation, or as required by applicable provisions of the DGCL
or applicable stock exchange rules, the affirmative vote of a majority of our shares of common stock that are voted is required
to approve any such matter voted on by our stockholders. Our stockholders are entitled to receive ratable dividends when, as and
if declared by our board of directors out of funds legally available therefor. We will consummate our initial business combination
only if we have net tangible assets of at least $5,000,001 upon such consummation and, solely if a vote is held to approve a business
combination, a majority of the outstanding shares of common stock voted are voted in favor of the business combination.

 

Our board of directors
is divided into two classes with only one class of directors being elected in each year and each class (except for those directors
appointed prior to our first annual meeting of stockholders) serving a two-year term. The term of office of the first class of
directors, consisting of General C. Robert Kehler and Donald W. Manvel, will expire at our first annual meeting of stockholders.
The term of office of the second class of directors, consisting of Eric J. Zahler, Sai S. Devabhaktuni and John C. Pescatore, will
expire at the second annual meeting of stockholders. We may not hold an annual meeting of stockholders until after we consummate
our initial business combination (unless required by the Nasdaq Capital Market, or Nasdaq). There is no cumulative voting with
respect to the election of directors, with the result that the holders of more than 50% of the shares eligible to vote for the
election of directors can elect all of the directors.

 

In accordance with
Nasdaq corporate governance requirements, we are not required to hold an annual meeting until one year after our first fiscal year
end following our listing on Nasdaq, or December 31, 2020. Under Section 211(b) of the DGCL, we are, however, required to hold
an annual meeting of stockholders for the purposes of electing directors in accordance with our amended and restated certificate
of incorporation unless such election is made by written consent in lieu of such a meeting. We may not hold an annual meeting of
stockholders to elect new directors prior to the consummation of our initial business combination, and thus we may not be in compliance
with Section 211(b) of the DGCL, which requires an annual meeting. Therefore, if our stockholders want us to hold an annual meeting
prior to the consummation of our initial business combination, they may attempt to force us to hold one by submitting an application
to the Delaware Court of Chancery in accordance with Section 211(c) of the DGCL.

 

We will provide our
public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business
combination at a per-share price which is payable in cash and equal to the aggregate amount then on deposit in the trust account
as of two business days prior to the consummation of our initial business combination, including interest (which interest shall
be net of taxes payable by us) divided by the number of then outstanding public shares, subject to the limitations more fully described
in our final prospectus. Our founders, executive officers and directors have entered into a letter agreement with us, pursuant
to which they have agreed to waive their redemption rights with respect to their founder shares, private shares and public shares
in connection with the completion of our business combination or any amendment to the provisions of our amended and restated certificate
of incorporation relating to our pre-initial business combination activity and related stockholders’ rights.

 

    

     

    

 

Unlike many blank
check companies that hold stockholder votes and conduct proxy solicitations in conjunction with their initial business combinations
and provide for related redemptions of securities even when a vote is not required by law, if a stockholder vote is not required
by law and we do not decide to hold a stockholder vote for business or other legal reasons, we will, pursuant to our amended and
restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer
documents with the SEC prior to completing our initial business combination. Our amended and restated certificate of incorporation
requires these tender offer documents to contain substantially the same financial and other information about the initial business
combination and the redemption rights as is required under the SEC’s proxy rules. If, however, stockholder approval of the
transaction is required by law, or we decide to obtain stockholder approval for business or other legal reasons, we will, like
many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not
pursuant to the tender offer rules.

 

If we seek stockholder
approval, we will complete our initial business combination only if a majority of the shares of common stock voting at a stockholder
meeting are voted in favor of the business combination. However, the participation of our founders, officers, directors, advisors
or their affiliates in privately-negotiated transactions, if any, could result in the approval of our business combination even
if a majority of our public stockholders vote, or indicate their intention to vote, against such business combination. For purposes
of seeking approval of the majority of our outstanding shares of common stock, non-votes will have no effect on the approval of
our business combination once a quorum is obtained. We intend to give approximately 30 days (but not less than 10 days nor more
than 60 days) prior written notice of any such meeting, if required, at which a vote shall be taken to approve our business combination.

 

If we seek stockholder
approval of our initial business combination and we do not conduct redemptions in connection with our business combination pursuant
to the tender offer rules, our amended and restated certificate of incorporation provides that a public stockholder, together with
any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group”
(as defined under Section 13 of the Securities Exchange Act of 1934, as amended, or the Exchange Act), will be restricted from
seeking redemption rights with respect to more than an aggregate of 15% of the shares sold in our initial public offering. However,
we would not be restricting our stockholders’ ability to vote all of their shares for or against our business combination.

 

If we seek stockholder
approval in connection with our business combination, our founders, executive officers and directors have agreed (and their permitted
transferees will agree) to vote their founder shares, private shares and any public shares purchased during or after our initial
public offering in favor of our initial business combination. As a result, we would need 6,110,001, or approximately 35.4%, of
the 17,250,000 public shares to be voted in favor of our initial business combination in order to have such transaction approved
(assuming all shares of our common stock are voted at the meeting). Additionally, each public stockholder may elect to redeem their
public shares without voting, and, if they do vote, irrespective of whether they vote for or against the proposed transaction.

 

Pursuant to our amended
and restated certificate of incorporation, if we are unable to complete our business combination by November 11, 2020 (or February
11, 2021, if we extend our time to complete a business combination as described in the Report), we will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, subject
to lawfully available funds therefor, redeem the public shares, at a per-share price which is payable in cash and equal to the
aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable by us and
up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption
will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation
distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject
to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations
under Delaware law to provide for claims of creditors and the requirements of other applicable law. Our founders, executive officers
and directors have entered into a letter agreement with us, pursuant to which they have agreed to (1) waive their redemption rights
with respect to any common stock held by them in connection with the completion of our initial business combination or any amendment
to the provisions of our amended and restated certificate of incorporation relating to our pre-initial business combination activity
and related stockholders’ rights and (2) waive their rights to liquidating distributions from the trust account with respect
to their founder shares if we fail to complete our business combination within the prescribed timeframe (although they will be
entitled to liquidating distributions from the trust account with respect to any public shares they hold).

 

In the event of a
liquidation, dissolution or winding up of the company after a business combination, our stockholders are entitled to share ratably
in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class
of stock, if any, having preference over the common stock. Our stockholders have no preemptive or other subscription rights. There
are no sinking fund provisions applicable to the common stock, except that we will provide our public stockholders with the opportunity
to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the trust account,
including interest (which interest shall be net of taxes payable by us) upon the completion of our initial business combination,
subject to the limitations more fully described in our final prospectus.

 

    

     

    

 

Warrants

 

As of the date of
the Report, there were 17,967,500 warrants to purchase our common stock outstanding, consisting of 17,250,000 public warrants and
717,500 private warrants held by our founders. Each warrant entitles the registered holder to purchase one share of our common
stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days
after the completion of our initial business combination. The warrants will expire at 5:00 p.m., New
York City time, on the fifth anniversary of our completion of an initial business combination, or earlier upon redemption or liquidation.

 

Holders of our public
warrants cannot pay cash to exercise of their public warrants unless we have an effective and current registration statement covering
the issuance of the shares underlying such warrants and a current prospectus relating thereto. Notwithstanding the foregoing, if
a registration statement covering the issuance of the shares issuable upon exercise of the public warrants is not effective within
90 days from the closing of our initial business combination, warrant holders may, until such time as there is an effective
registration statement and during any period when we shall have failed to maintain an effective registration statement or a current
prospectus, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act
of 1933, as amended, or the Securities Act. If an exemption from registration is not available, holders will not be able to exercise
their warrants on a cashless basis. In no event will we be required to net cash settle any warrant, or issue securities or other
compensation in exchange for the warrants in the event that we are unable to register or qualify the shares underlying the warrants
under the Securities Act or applicable state securities laws. In addition, any private warrants held by Cowen Investments will
not be exercisable more than five years from February 6, 2019.

 

The private warrants
are identical to the public warrants underlying the units sold in our initial public offering except that such private warrants
will be exercisable for cash (even if a registration statement covering the issuance of the warrant shares issuable upon exercise
of such warrants is not effective) or on a cashless basis, at the holder’s option, and will not be redeemable by us, in each
case so long as they are still held by our founders or their affiliates.

 

Once the warrants
become exercisable, we may redeem the outstanding warrants (excluding the private warrants):

 

		·	in whole and not in part;

 

		·	at a price of $0.01 per warrant;

 

		·	upon a minimum of 30 days’ prior written notice of redemption,
which we refer to as the 30-day redemption period; and

 

		·	if, and only if, the last reported sale price of our common stock
equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like)
for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice
of redemption to the warrant holders.

 

We will not redeem the warrants unless
a registration statement under the Securities Act covering the issuance of the warrant shares underlying the warrants to be so
redeemed is then effective and a current prospectus relating to those warrant shares is available throughout the 30-day redemption
period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under
the Securities Act. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable
to register or qualify the underlying securities for sale under all applicable state securities laws.

 

If the foregoing conditions
are satisfied and we issue a notice of redemption, each warrant holder may exercise his, her or its warrants prior to the scheduled
redemption date. However, the price of the shares of common stock may fall below the $18.00 trigger price (as adjusted) as well
as the $11.50 exercise price (as adjusted) after the redemption notice is issued.

 

The redemption criteria
for our warrants have been established at a price which is intended to provide warrant holders a reasonable premium to the initial
exercise price and provide a sufficient differential between the then-prevailing share price and the exercise price so that if
the share price declines as a result of our redemption call, the redemption will not cause the share price to drop below the exercise
price of the warrants.

 

    

     

    

 

If we call the warrants
for redemption as described above, our management will have the option to require all holders that wish to exercise warrants to
do so on a “cashless basis.” In making such determination, our management will consider, among other factors, our cash
position, the number of warrants that are outstanding and the dilutive effect on our stockholders of issuing the maximum number
of warrant shares issuable upon exercise of outstanding warrants. In such event, the holder would pay the exercise price by surrendering
the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number
of warrant shares underlying the warrants to be so exercised, and the difference between the exercise price of the warrants and
the fair market value by (y) the fair market value.

 

A holder of a warrant
may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise
such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates),
to the warrant agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder
may specify) of the shares of common stock outstanding immediately after giving effect to such exercise.

 

If the number of outstanding
shares of common stock is increased by a stock dividend payable in shares of common stock, or by a split-up of shares of common
stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares
of common stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding shares
of common stock. A rights offering to holders of common stock entitling holders to purchase shares of common stock at a price less
than the fair market value will be deemed a stock dividend of a number of shares of common stock equal to the product of 
(i) the number of shares of common stock actually sold in such rights offering (or issuable under any other equity securities
sold in such rights offering that are convertible into or exercisable for common stock) multiplied by (ii) one (1) minus the
quotient of  (x) the price per share of common stock paid in such rights offering divided by (y) the fair market
value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for common stock, in
determining the price payable for common stock, there will be taken into account any consideration received for such rights, as
well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average
price of common stock as reported during the 10 trading day period ending on the trading day prior to the first date on which the
shares of common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive
such rights.

 

In addition, if we,
at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other
assets to the holders of common stock on account of such shares of common stock (or other shares of our capital stock into which
the warrants are convertible), other than (a) as described above, (b) certain ordinary cash dividends, (c) to satisfy
the redemption rights of the holders of common stock in connection with a proposed initial business combination or the approval
of any amendment to the provisions of our amended and restated certificate of incorporation relating to our pre-initial business
combination activity and related stockholders’ rights, including the substance or timing of our obligation to redeem 100%
of our public shares if we do not complete our initial business combination within the required time period, (d) as a result
of the repurchase of shares of common stock by us if the proposed initial business combination is presented to our stockholders
for approval, or (e) in connection with the redemption of our public shares upon our failure to complete our initial business
combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by
the amount of cash and/or the fair market value of any securities or other assets paid on each share of common stock in respect
of such event.

 

If the number of outstanding
shares of our common stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of common
stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification
or similar event, the number of shares of common stock issuable on exercise of each warrant will be decreased in proportion to
such decrease in outstanding shares of common stock.

 

Whenever the number
of shares of common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price
will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator
of which will be the number of shares of common stock purchasable upon the exercise of the warrants immediately prior to such adjustment,
and (y) the denominator of which will be the number of shares of common stock so purchasable immediately thereafter.

 

    

     

    

 

In case of any reclassification
or reorganization of the outstanding shares of common stock (other than those described above or that solely affects the par value
of such shares of common stock), or in the case of any merger or consolidation of us with or into another corporation (other than
a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization
of our outstanding shares of common stock), or in the case of any sale or conveyance to another corporation or entity of the assets
or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of
the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified
in the warrants and in lieu of the shares of our common stock immediately theretofore purchasable and receivable upon the exercise
of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable
upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer,
that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event.
However, if such holders were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets
receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each warrant
will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders in
such consolidation or merger that affirmatively make such election, and if a tender, exchange or redemption offer has been made
to and accepted by such holders (other than a tender, exchange or redemption offer made by the company in connection with redemption
rights held by stockholders of the company as provided for in our amended and restated certificate of incorporation or as a result
of the repurchase of shares of common stock by the company if a proposed initial business combination is presented to the stockholders
of the company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof,
together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such maker is
a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act)
and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3
under the Exchange Act) more than 50% of the outstanding shares of common stock, the holder of a warrant will be entitled to receive
the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder
if such warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer, accepted such offer
and all of the common stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments
(from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided
for in the Warrant Agreement. Additionally, if less than 70% of the consideration receivable by the holders of common stock in
such a transaction is payable in the form of common stock in the successor entity that is listed for trading on a national securities
exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following
such event, and if the registered holder of the warrant properly exercises the warrant within 30 days following public disclosure
of such transaction, the warrant exercise price will be reduced as specified in the Warrant Agreement based on the per share consideration
minus Black-Scholes Warrant Value (as defined in the Warrant Agreement) of the warrant in order to determine and realize the option
value component of the warrant. This formula is to compensate the warrant holder for the loss of the option value portion of the
warrant due to the requirement that the warrant holder exercise the warrant within 30 days of the event. The Black-Scholes
model is an accepted pricing model for estimating fair market value where no quoted market price for an instrument is available.

 

The warrants are issued
in registered form under the Warrant Agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us.
The Warrant Agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity
or correct any defective provision, but requires the approval by the holders of at least 65% of the then outstanding public warrants
to make any change that adversely affects the interests of the registered holders of public warrants.

 

The warrants may be
exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with
the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment
of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to us, for the number
of warrants being exercised. The warrant holders do not have the rights or privileges of holders of common stock and any voting
rights until they exercise their warrants and receive shares of common stock. After the issuance of shares of common stock upon
exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on
by stockholders.

 

Preferred Stock

 

As of the date of
the Report, there were no shares of preferred stock outstanding. Our amended and restated certificate of incorporation authorizes
the issuance of 5,000,000 shares of preferred stock with such designation, rights and preferences as may be determined from time
to time by our board of directors. Accordingly, our board of directors is empowered, without stockholder approval, to issue preferred
stock with dividend, liquidation, conversion, voting or other rights which could adversely affect the voting power or other rights
of the holders of common stock. However, the underwriting agreement from our initial public offering prohibits us, prior to a business
combination, from issuing preferred stock which participates in any manner in the proceeds of the trust account, or which votes
as a class with the common stock on a business combination. We may issue some or all of the preferred stock to effect a business
combination. In addition, the preferred stock could be utilized as a method of discouraging, delaying or preventing a change in
control of us.

 

Private Units

 

The private units
are identical to the units sold in our initial public offering, except that, if held by the original holder or their permitted
assigns, the underlying warrants (i) may be exercised on a cashless basis, (ii) are not subject to redemption and (iii) with respect
to private warrants held by Cowen Investments, will not be exercisable after five years from February 6, 2019. In addition, the
private units (and the securities underlying the private units) will, subject to certain limited exceptions, be subject to transfer
restrictions until after the completion of our initial business combination.

 

    

     

    

 

Dividends

 

We have not paid any
cash dividends on our shares of common stock to date and do not intend to pay cash dividends prior to the completion of a business
combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements
and general financial condition subsequent to completion of a business combination. The payment of any dividends subsequent to
a business combination will be within the discretion of our then board of directors. It is the present intention of our board of
directors to retain all earnings, if any, for use in our business operations and, accordingly, our board of directors does not
anticipate declaring any dividends in the foreseeable future. Further, if we incur any indebtedness, our ability to declare dividends
may be limited by restrictive covenants we may agree to in connection therewith.

 

Our Transfer Agent and Warrant Agent

 

The transfer agent
for our securities and warrant agent for our warrants is Continental Stock Transfer & Trust Company, One State Street, New
York, New York 10004.

 

Listing of Securities

 

Our units, common
stock and warrants are listed on the Nasdaq Capital Market under the symbols “MNCLU,” “MNCL” and “MNCLW,”
respectively.

 

Certain Anti-Takeover Provisions of
Delaware Law and our Amended and Restated Certificate of Incorporation

 

Special meeting of stockholders

 

Our amended and restated
certificate of incorporation provides that special meetings of our stockholders may be called only by a majority vote of our board
of directors, by our Chief Executive Officer or by our Chairman.

 

Advance notice requirements for stockholder proposals and
director nominations

 

Our bylaws provide
that stockholders seeking to bring business before our annual meeting of stockholders, or to nominate candidates for election as
directors at our annual meeting of stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder’s
notice will need to be received by the company secretary at our principal executive offices not later than the close of business
on the 90th day nor earlier than the open of business on the 120th day prior to the anniversary date of the immediately
preceding annual meeting of stockholders. Pursuant to Rule 14a-8 of the Exchange Act, proposals seeking inclusion in our annual
proxy statement must comply with the notice periods contained therein. Our amended and restated certificate of incorporation specifies
certain requirements as to the form and content of a stockholders’ meeting. These provisions may preclude our stockholders
from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting
of stockholders.

 

Authorized but unissued shares

 

Our authorized but
unissued common stock and preferred stock are available for future issuances without stockholder approval and could be utilized
for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit
plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more difficult or
discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

 

Exclusive forum selection

 

Our amended and restated
certificate of incorporation requires, to the fullest extent permitted by law, that derivative actions brought in our name, actions
against directors, officers and employees for breach of fiduciary duty and other similar actions may be brought only in the Court
of Chancery in the State of Delaware and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have
consented to service of process on such stockholder’s counsel; provided that the exclusive forum provision will not apply
to (i) suits brought to enforce any liability or duty created by the Exchange Act, (ii) any other claim for which the federal courts
have exclusive jurisdiction, (iii) any claim as to which the Court of Chancery determines that there is an indispensable party
not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction
of the Court of Chancery within ten days following such determination), (iv) any claim which is vested in the exclusive jurisdiction
of a court or forum other than the Court of Chancery, or (v) any claim for which the Court of Chancery does not have subject matter
jurisdiction. Furthermore, our amended and restated certificate of incorporation provides that unless we consent in writing to
the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution
of any complaint asserting a cause of action arising under the Securities Act. Although we believe this provision benefits our
company by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, a court
may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging
lawsuits against our directors and officers, although our stockholders will not be deemed to have waived our compliance with federal
securities laws and the rules and regulations thereunder.

 

    

     

    

 

Section 203 of the Delaware General Corporation Law

 

We have opted out
of Section 203 of the DGCL. However, our amended and restated certificate of incorporation contains similar provisions providing
that we may not engage in certain “business combinations” with any “interested stockholder” for a three-year
period following the time that the stockholder became an interested stockholder, unless:

 

		·	prior to such time, our board of directors approved either the business
combination or the transaction which resulted in the stockholder becoming an interested stockholder;

 

		·	​upon consummation of the transaction that resulted in the stockholder
becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the
transaction commenced, excluding certain shares; or

 

		·	at or subsequent to that time, the business combination is approved
by our board of directors and by the affirmative vote of holders of at least 66 2∕3% of the outstanding voting stock that
is not owned by the interested stockholder.

 

Generally, a “business
combination” includes a merger, asset or stock sale or certain other transactions resulting in a financial benefit to the
interested stockholder. Subject to certain exceptions, an “interested stockholder” is a person who, together with that
person’s affiliates and associates, owns, or within the previous three years owned, 15% or more of our voting stock.

 

Under certain circumstances,
this provision will make it more difficult for a person who would be an “interested stockholder” to effect various
business combinations with a corporation for a three-year period. This provision may encourage companies interested in acquiring
our company to negotiate in advance with our board of directors because the stockholder approval requirement would be avoided if
our board of directors approves either the business combination or the transaction which results in the stockholder becoming an
interested stockholder. These provisions also may have the effect of preventing changes in our board of directors and may make
it more difficult to accomplish transactions which stockholders may otherwise deem to be in their best interests.

 

Our amended and restated
certificate of incorporation provides that our sponsor and its respective affiliates, any of their respective direct or indirect
transferees of at least 15% of our outstanding common stock and any group as to which such persons are party to, do not constitute
 “interested stockholders” for purposes of this provision.

 

Our amended and restated
certificate of incorporation provides that our board of directors is classified into two classes of directors. As a result, in
most circumstances, a person can gain control of our board only by successfully engaging in a proxy contest at two or more annual
meetings.

 

Our authorized but
unissued common stock and preferred stock are available for future issuances without stockholder approval and could be utilized
for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit
plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more difficult or
discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

 

Limitation on Liability and Indemnification
of Directors and Officers

 

Our amended and restated
certificate of incorporation provides that our directors and officers will be indemnified by us to the fullest extent authorized
by Delaware law as it now exists or may in the future be amended. In addition, our amended and restated certificate of incorporation
provides that our directors will not be personally liable for monetary damages to us for breaches of their fiduciary duty as directors,
unless they violated their duty of loyalty to us or our stockholders, acted in bad faith, knowingly or intentionally violated the
law, authorized unlawful payments of dividends, unlawful stock purchases or unlawful redemptions, or derived an improper personal
benefit from their actions as directors.

 

Our bylaws also permit
us to secure insurance on behalf of any officer, director or employee for any liability arising out of his or her actions, regardless
of whether Delaware law would permit indemnification. We may purchase a policy of directors’ and officers’ liability
insurance that insures our directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances
and insures us against our obligations to indemnify the directors and officers.

 

These provisions may
discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also
may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action,
if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely
affected to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification
provisions. We believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented
and experienced directors and officers.

 

Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to
the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable.lstg_ex101.htm

EXHIBIT 10.1

 
BRANDING AGREEMENT

 
THIS BRANDING AGREEMENT 
(the “Agreement
”), with an effective date of February 28, 2020 (the “Effective Date
”), is entered into by and between Good Hemp, Inc. (the “Company
”) and Spire Holdings, LLC (“Spire
”). Each of the Parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties.”
 
WHEREAS:

 
	 
	A.	Spire possesses the rights to the NASCAR Cup Series No. 77 entry automobile, team and drivers (the “Car
”), as well as rights to provide brand promotion at Track Enterprises racing events across the United States and Rapid City Rush ECHL Hockey home games;
	 
	 
	 

	 
	B.	The Company desires to retain Spire to use its assets described in Exhibits A through E attached hereto to promote the Company’s Good Hemp brand of beverages on the terms and conditions stated herein; and
	 
	 
	 

	 
	C.	The Parties agree that this Agreement reflects the entire understanding and agreements between the Parties hereto regarding the subject matter hereof.

 
AGREEMENT
:
 
In consideration of the foregoing and of the mutual promises set forth herein, and intending to be legally bound, the Parties hereto agree as follows:
 
1. Sponsorship
. Spire shall provide the Company rights to the following, on a best effort’s basis subject to NASCAR and network television approval (the “Approval”):
  
	 
	a.	Seven (7) primary sponsorships on the Car pursuant to the Primary Sponsorship Company branding plans attached hereto as Exhibit A
, and for the dates set forth in Exhibit B
.
	 
	 
	 

	 
	b.	Twenty-Five (25) associate or secondary sponsorships on the Car for the dates set forth in Exhibit B.

 
The Company understands that hemp brands have not been accepted to date by NASCAR and agrees that the Sponsorship outlined in Section 1(a) and 1(b) is subject to Approval. The Company further agrees that Compensation defined in Section 2 is not subject to Approval and Spire will not be held responsible if the Good Hemp brand is not accepted for Approval. In the event Approval is not obtained, Spire will continue a best efforts basis, to periodically seek Approval with NASCAR to fulfill the Sponsorship outlined in Section 1(a) and 1(b).
 

	 
	1
	 

	 

 
Spire shall also provide the Company rights to the following:
 
	 
	a.	Sponsorship at thirty (30) Track Enterprises racing events set forth in Exhibit C
, pursuant to the Company branding plans attached hereto as Exhibit D
.
	 
	 
	 

	 
	b.	“Home” sponsorship of Rapid City Rush ECHL Hockey games for twelve months pursuant to the Company branding plans attached hereto as Exhibit
 E
.

 
2. Compensation
. The Company shall pay Spire a sponsorship fee consisting of 6,000,000 shares of Company common stock (the “Shares
”). During the term of this Agreement, and for five (5) years thereafter, if the Company issues William Alessi or Chris Chumas additional shares of capital stock in conversion of their promissory notes (the “Alessi or Chumas Issuance
”), the Company shall immediately issue Spire (the “Antidilution Issuance
”) an additional number of shares of Company common stock such that Spire’s percentage ownership of the Company after the Alessi or Chumas Issuance will be the same as Spire’s percentage ownership of the Company prior to the Alessi or Chumas Issuance. Shares will be issued to Company pursuant to the attached Exhibit F.
 
3. Piggyback Registration Rights
. If the Company files a registration statement with the United States Securities and Exchange Commission (the “SEC
”) registering shares of common stock held by its shareholders for resale (“Resale Registration
”), the Resale Registration shall register a number of Spire shares equal to the following: the total number of outstanding shares registered for resale multiplied by (a) the number of shares held by Spire divided by (b) the number of outstanding shares of the Company, rounded up to the nearest share. As an example for clarity, if 6,000,000 shares were held by Spire, 7,500,000 shares were held by William Alessi, 7,500,000 shares were held by Chris Chumas, a total of 22,500,000 shares of Company stock were outstanding, and the Company filed a registration statement with the SEC registering 9,000,000 shares for sale by the Company, and 1,000,000 shares for resale by the Company’s existing shareholders, 266,667 of the 1,000,000 shares registered for resale would be registered for Spire.
 
4. Spire's Business Activities
. For six months following the termination of all of the sponsorship rights provided to the Company hereunder, Spire shall not offer sponsorship rights to any other business engaged in the production or distribution of hemp or cannabis products unless mutually agreed to in writing by both Parties.
 
5. Patent Rights, Invention and Intellectual Property
. The Company hereby grants Spire a limited non-exclusive, license to use the Company’s branding in connection with the sponsorship rights granted to the Company hereunder. All rights, title and interest to any and all inventions, discoveries, data, biological materials or software arising from any work or research conducted under this Agreement, whether or not patentable, shall belong to the Company, and Spire hereby covenants and agrees to fully cooperate in the execution of any documents (whether an assignment of intellectual property to the Company or otherwise) which may be at any time requested by Company.
 
6. Indemnification
. Each Party hereby indemnifies and agrees to defend and hold harmless the other from and against any and all claims, demands and actions, and any liabilities, damages or expenses resulting therefrom, including court costs and reasonable attorneys' fees, arising out of any breach of this Agreement or the representations and warranties made by the Parties. The Parties' obligations under this Paragraph 6 hereof shall survive the termination, for any reason, of this Agreement.
 

	 
	2
	 

	 

 
7. Compliance with Securities Laws
. The Parties understand and agree that any and all shares being issued to Spire hereunder are being issued solely in consideration of the sponsorship rights being provided to Spire to the Company hereunder, and that Spire’s relationship with the Company does not involve the promotion or marketing of the Company’s securities (including its common stock), nor does it involve raising money for the Company.
 
8. Attorney's Fees
. Should either Party hereto, or any heir, personal representative, successor or assign of either Party hereto, resort to litigation to enforce this Agreement, the Party or Parties prevailing in such litigation shall be entitled, in addition to such other relief as may be granted, to recover its or their reasonable attorneys' fees and costs in such litigation from the Party or Parties against whom enforcement was sought, subject to the provisions of Paragraph 20.
 
9. Entire Agreement
. This Agreement contains the entire understanding and agreement between the Parties hereto with respect to its subject matter and supersedes any prior or contemporaneous written or oral agreements, representations or warranties between them respecting the subject matter hereof.
 
10. Amendment
. This Agreement may be amended only by a writing signed by Spire and by a representative of the Company duly authorized.
 
11. Severability
. If any provision of this Agreement, as applied to either Party or to any circumstances, shall be adjudged by a court to be void or unenforceable, the same shall be deemed stricken from this Agreement and shall in no way affect any other provision of this Agreement or the validity or enforceability of this Agreement. In the event any such provision (the “Applicable
 Provision
”) is so adjudged void or unenforceable, Spire and the Company shall take the following actions in the following order: (i) seek judicial reformation of the Applicable Provision; (ii) negotiate in good faith with each other to replace the Applicable Provision with a lawful provision; and (iii) have an arbitration as provided in Paragraph 20 hereof determine a lawful replacement provision for the Applicable Provision; provided, however, that no such action pursuant to either of clauses (i) or (iii) above shall increase in any respect Spire’s obligations pursuant to the Applicable Provision.
 
12. Rights Cumulative
. The rights and remedies provided by this Agreement are cumulative, and the exercise of any right or remedy by either Party hereto (or by its successors), whether pursuant to this Agreement, to any other agreement, or to law, shall not preclude or waive its right to exercise any or all other rights and remedies.
 
13. Nonwaiver
. No failure or neglect of either Party hereto in any instance to exercise any right, power or privilege hereunder or under law shall constitute a waiver of any other right, power or privilege or of the same right, power or privilege in any other instance. All waivers by either Party hereto must be contained in a written instrument signed by the Party to be charged and, in the case of the Company, by an executive officer of the Company or other person duly authorized by the Company.

	 
	3
	 

	 

 
14. No Mitigation
. In the event this Agreement is terminated for any reason prior to its expiration, Spire shall not be required to mitigate damages hereunder, nor shall the Company be entitled to offset from any sums owing to Spire under the terms of this Agreement.
 
15. No Implied Contract
. The Parties intend to be bound only upon execution of this Agreement and no negotiation, exchange or draft or partial performance shall be deemed to imply an agreement. Neither the continuation of the provision of sponsorship rights by Spire nor any other conduct shall be deemed to imply a continuing agreement upon the expiration of this Agreement.
 
16. Execution of the Agreement
. The parties executing this Agreement on behalf of the Company and Spire have the requisite corporate power and authority to enter into and carry out the terms and conditions of this Agreement, as well as all transactions contemplated hereunder. All corporate proceedings have been taken and all corporate authorizations and approvals have been secured which are necessary to authorize the execution, delivery and performance by each of the Parties to this Agreement. This Agreement has been duly and validly executed and delivered by the Company and Spire and constitutes the valid and binding obligations of the Company and Spire, enforceable in accordance with the respective terms. Upon complete execution of this Agreement, this Agreement, will constitute the valid and binding obligations of each of the Parties, and will be enforceable in accordance with its terms.
 
17. Confidentiality
.
 
(a) For purposes of this Agreement, “Protected Information
” subject to the provisions of Paragraph 17(b) means: (a) all work product; and (b) all trade secrets or other confidential or proprietary information owned, developed or possessed by the Company or any of its affiliates, whether in tangible or intangible form, pertaining to the business of the Company or any of its affiliates, including, without limitation, research and development operations, systems, databases, computer programs and software, designs, models, operating procedures, knowledge of the organization, products (including process, costs, sales or content), processes, techniques, machinery, contracts, financial information or prospective customers, identities or individual contacts of business entities which are customers or prospective customers, preferences, business or habits and business relationships, whether developed prior to the date of this Agreement or hereafter, and made known to Spire, whether or not developed, devised or otherwise created in whole or in part by Spire's efforts, by reason of Spire's agreement with the Company.
 
(b) Notwithstanding Paragraph 17(a), Protected Information will not include information which: (a) at or prior to the time of disclosure by the Company to Spire was already known to Spire (as evidenced in writing), except to the extent unlawfully appropriated; (b) at or after the time of disclosure by the Company to Spire becomes generally available to the public other than through any act or omission on Spire's part; or (c) Spire receives from a third party free to make such disclosure without breach of any legal obligation.
 
(c) No Unauthorized Use or Disclosure of Protected Information
.

	 
	4
	 

	 

 
(i) For two years following the Effective Date, Spire agrees that it will maintain the Protected Information in strict confidence and shall use the Protected Information only for the purposes set forth in this Agreement.
 
(ii) For two years following the Effective Date, Spire agrees that it will not: (i) use or disclose any Protected Information in contravention of the Company's policies or procedures made known to Spire; (ii) use or disclose any Protected Information in contravention of any lawful instruction or directive, either written or oral, of any Company employee; (iii) use or disclose any Protected Information in contravention of any duty existing under law or contract; (iv) use or disclose any Protected Information knowingly to the detriment of the Company; (v) use or disclose any Protected Information to any third party without the express written consent of the Company; (vi) use or disclose any Protected Information for a purpose other than for which Spire is authorized under this Agreement; or (vii) otherwise take any action inconsistent with the Company's measures to protect its interests in the Protected Information, or any action which would constitute or facilitate the unauthorized use or disclosure of Protected Information.
 
(d) Promptly upon the termination of the sponsorship rights under this Agreement, or any time at the request of the Company, Spire will deliver to the Company all property or materials within Spire's possession or control which belong to the Company or its affiliates or which contain or are based upon Protected Information (including notes, presentations, reports, charts, spreadsheets and other documents which contain or reflect Protected Information).
 
(e) If Spire is required to disclose any Protected Information pursuant to any applicable statute, regulation, order, subpoena or document discovery request, Spire may do so, provided that prior written notice of such disclosure is furnished to the Company as soon as practicable in order to afford the Company an opportunity to seek a protective order.
 
18. Successors and Assigns
. Subject to the other provisions of this Agreement, the rights and obligations of the Company under this Agreement shall be binding on and inure to the benefit of the Company, its successors and permitted assigns. The rights and obligations of Spire under this Agreement shall be binding on and inure to the benefit of the heirs and legal representatives of Spire.
 
19. Agreement to Perform Necessary Acts
. Spire and the Company agree to perform any further acts and execute and deliver any documents that may be reasonably necessary to carry out the provisions of this Agreement.
 
20. Assignment
. Spire may not assign this Agreement without the Company's prior written consent. This Agreement may be assigned by the Company in connection with a merger, corporate reorganization or sale of all or substantially all of its assets, and in other instances with Spire's consent which consent shall not be unreasonably withheld or delayed. Shares issuable to Spire under this Agreement shall be assignable at the discretion of Spire.
 

	 
	5
	 

	 

 
21. Notices
: Any notice required or permitted to be given hereunder shall be in writing and shall be mailed or otherwise delivered in person or by facsimile transmission to such address or facsimile telephone number as the Party shall have furnished in writing to the other Party.
 
22. Governing Law
. This Agreement and all matters or issues collateral thereto shall be governed by the laws of the State of North Carolina applicable to contracts entered into and performed entirely therein.
 
23. Facsimile Certification
. A facsimile copy of this Agreement signed by any and/or all Parties shall have the same binding and legal effect as an original of the same.
 
24. Counterparts
. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one in the same instrument. Regardless of whether this Agreement is executed in one or more counterparts, each such counterpart may be executed by actual or facsimile signature(s).
 
[signature page follows]

	 
	6
	 

	 

 
IN WITNESS WHEREOF, this Agreement has been executed by the Parties as of the date first above written.
 
	 	THE COMPANY:
 
G
ood Hemp, Inc.

	
	 	 	 	 
	Date: 2/27/2020	By:	/s/ William Alessi
	
	 
	Name:
	William Alessi	 
	 	Title:	Chief Executive Officer	 

   
	 	SPIRE: 

 
Spire Holdings, LLC

	
	 	 	 	 
	Date: 2/27/2020	By:	/s/ TJ Puchyr
	
	 
	Name:
	TJ Puchyr	 
	 	Title:	Managing Member	 

 
	 
	7
	 

	 

 
EXHIBIT
 A 

 
Primary Sponsorship Assets 
 
Spire Motorsports 
No. 77 Entry 
NASCAR Cup Series 
 
	 
	·

	Primary sponsorship of No. 77 entry including design rights and branding on hood, quarter-panels, T.V. panel and roof-strip
	 
	·

	Marketing rights to team and driver through 12/31/2020
	 
	·

	Race day hospitality package for 8 guests (NASCAR Hot Pass Credentials)
	 
	·

	Two rotating seats on pit box during race
	 
	·

	Private access to race day activities including guided garage and hauler tour
	 
	·

	Private meet & greet with driver on race day
	 
	·

	Team and driver social media support throughout race weekend
	 
	·

	Public relations support throughout race weekend
	 
	·

	Sponsorship press release to endemic motorsports media before event
	 
	·

	Photo opportunity with car and driver on pit road pre-race

 

	 
	 
	 

	 

 
EXHIBIT
 B 

 
Sponsorships Races and Dates 
 
Spire Motorsports 
No. 77 Entry 
NASCAR Cup Series 
 
PRIMARY 
 
	 
	1.	Atlanta 3/15/2020
	 
	2.	Miami 3/22/2020
	 
	3.	Texas 3/29/2020
	 
	4.	Martinsville 5/9/2020
	 
	5.	Charlotte All Star 5/16/2020
	 
	6.	Richmond 9/12/2020
	 
	7.	Texas 10/25/2020

 
ASSOCIATE 
 
	 
	1.	Bristol 4/5/2020
	 
	2.	Richmond 4/19/2020
	 
	3.	Talladega 4/26/2020
	 
	4.	Dover 5/3/2020
	 
	5.	Kansas 5/31/2020
	 
	6.	Michigan 6/7/2020
	 
	7.	Sonoma 6/14/2020
	 
	8.	Chicago 6/21/2020
	 
	9.	Pocono 6/27/2020
	 
	10.	Pocono 6/28/2020
	 
	11.	Indianapolis 7/5/2020
	 
	12.	Kentucky 7/11/2020
	 
	13.	New Hampshire 7/19/2020
	 
	14.	Michigan 8/9/2020
	 
	15.	Watkins Glen 8/16/2020
	 
	16.	Dover 8/23/2020
	 
	17.	Daytona 8/29/2020
	 
	18.	Darlington 9/6/2020
	 
	19.	Bristol 9/19/2020
	 
	20.	Las Vegas 9/27/2020
	 
	21.	Talladega 10/4/2020
	 
	22.	Charlotte 10/11/2020
	 
	23.	Kansas 10/18/2020
	 
	24.	Martinsville 11/1/2020
	 
	25.	Phoenix 11/8/2020

 

	 
	 
	 

	 

 
EXHIBIT
 C 

 
Track Enterprises Events
 
		1.
	Pensacola 3/13/2020 

		2.
	Terre Haute 4/26/2020 

		3.
	Kansas City 5/1/2020 

		4.
	Pevely 5/2/2020 

		5.
	Nashville 5/2/2020 

		6.
	Terre Haute 5/20/2020 

		7.
	Terre Haute 5/21/2020 

		8.
	Indianapolis 5/22/2020 

		9.
	Sun Prairie 5/31/2020 

		10. 
	Terre Haute 6/6/2020 

		11. 
	Milwaukee 6/14/2020 

		12. 
	Wilmot 6/21/2020 

		13. 
	Indianapolis 7/3/2020 

		14. 
	Eldon 7/3/2020 

		15. 
	Greenwood 7/9/2020 

		16. 
	Elko 7/11/2020 

		17. 
	Terre Haute 7/12/2020 

		18. 
	Nashville 7/18/2020 

		19. 
	Terre Haute 7/29/2020 

		20. 
	Madison 8/2/2020 

		21. 
	Madison 8/7/2020 

		22. 
	Terre Haute 8/16/2020 

		23. 
	Springfield 8/22/2020 

		24. 
	Springfield 8/23/2020 

		25. 
	Duquoin 9/5/2020 

		26. 
	Duquoin 9/6/2020 

		27. 
	Terre Haute 9/18/2020 

		28. 
	Nashville 10/31/2020 

		29. 	TBD 

		30. 	TBD 

 

	 
	 
	 

	 

 
EXHIBIT
 D 

 
Track Enterprise Assets 
 
	 
	1.	Banners
	 
	2.	Sampling (where permissible)
	 
	3.	Activation Space
	 
	4.	Social Media Integration
	 
	5.	Product Sales (where permissible)
	 
	6.	P.A. Announcements

 

	 
	 
	 

	 

 
EXHIBIT
 E 

 
Rapid City Rush Assets 
 
	 
	1.	Social Media Integration
	 
	2.	Product Activation
	 
	3.	Website Placement
	 
	4.	Marketing Strategy around Rush

 

	 
	 
	 

	 

 
EXHIBIT F

 
SPIRE HOLDINGS LLC

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]